Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage Intelligence
Tóm tắt
Từ khóa
Tài liệu tham khảo
Campbell M, Gonzalez NM, Silva RR: The pharmacological treatment of conduct disorders and rage outbursts. Psychiatr Clin North Am 1992; 15:69-85
Campbell M, Malone RP: Mental retardation and psychiatric disorders. Hosp Community Psychiatry 1991; 42:374-379
Lovell RW, Reiss AL: Dual diagnoses: psychiatric disorders in developmental disabilities. Pediatr Clin North Am 1993; 40:579-592
Moss S, Emerson E, Bouras N, Holland A: Mental disorders and problematic behaviours in people with intellectual disability: future directions for research. J Intellect Disabil Res 1997; 41:440-447
Schaal DW, Hackenberg T: Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities. Am J Ment Retard 1994; 99:123-140
Santosh PJ, Baird G: Psychopharmacotherapy in children and adults with intellectual disability. Lancet 1999; 354:233-242
Lavin MR, Rifkin A: Diagnosis and pharmacotherapy of conduct disorder. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:875-885
Moretti MM, Emmrys C, Grizenko N, Holland R, Moore K, Shamsie J, Hamilton H: The treatment of conduct disorder: perspectives from across Canada. Can J Psychiatry 1997; 42:637-648
Brestan EV, Eyberg SM: Effective psychosocial treatments of conduct-disordered children and adolescents: 29 years, 82 studies, and 5,272 kids. J Clin Child Psychol 1998; 27:180-189
Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL: A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:509-516
Van Bellinghen M, De Troch C: Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 2001; 11:5-13
Buitelaar JK, van der Gaag, RJ, Cohen-Kettenis P, Melman CTM: A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 2001; 62:239-248
Kewley GD: Risperidone in comorbid ADHD and ODD/CD. J Am Acad Child Adolesc Psychiatry 1999; 38:1327-1328
Hardan A, Johnson K, Johnson C, Hrecznyj B: Case study: risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry 1996; 35:1551-1556
Fras I, Major LF: Clinical experience with risperidone (letter). J Am Acad Child Adolesc Psychiatry 1995; 34:833
Carroll NB, Boehm KE, Strickland RT: Chorea and tardive dyskinesia in a patient taking risperidone. J Clin Psychiatry 1999; 60:485-487
Kleinsasser BJ, Misra LK, Bhatara VS, Sanchez JD: Risperidone in the treatment of choreiform movements and aggressiveness in a child with “PANDAS.” SD J Med 1999; 52:345-347
Schreier HA: Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 1998; 8:49-59
Simeon JG, Carrey NJ, Wiggins DM, Milin RP, Hosenbocus SN: Risperidone effects in treatment-resistant adolescents: preliminary case reports. J Child Adolesc Psychopharmacol 1995; 5:69-79
Posey DJ, Walsh KH, Wilson GA, McDougle CJ: Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 1999; 9:273-276
Horrigan JP, Sikich L: Diet and the atypical neuroleptics. J Am Acad Child Adolesc Psychiatry 1998; 37:1126-1127
McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ: Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Am Acad Child Adolesc Psychiatry 1997; 36:683-693
Demb H: Risperidone in young children with pervasive developmental disorders and other developmental disabilities. J Child Adolesc Psychopharmacol 1996; 6:79-80
Fisman S, Steele M, Short J, Byrne T, Lavallee C: Case study: anorexia nervosa and autistic disorder in an adolescent girl. J Am Acad Child Adolesc Psychiatry 1996; 35:937-940
Fisman S, Steele M: Use of risperidone in pervasive development disorders: a case series. J Child Adolesc Psychopharmacol 1996; 6:177-190
Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR: Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol 1999; 9:115-123
Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, Kim GS, Shapiro S: Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999; 38:960-965
Findling RL, Maxwell K, Wiznitzer M: An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull 1997; 33:155-159
Vanden Borre R, Vermote R, Buttiens M, Thiry P, Dierick G, Geutjens J, Sieben G, Heylen S: Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 1993; 87:167-171
Nicolson R, Awad G, Sloman L: An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry 1998; 37:372-376
Horrigan JP, Barnhill LJ: Risperidone and explosive aggressive autism. J Autism Dev Disord 1997; 27:313-323
Simon EW, Blubaugh KM, Pippidis M: Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Ment Retard 1996; 34:359-366
Khan BU: Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord 1997; 27:479-489
Cohen SA, Ihrig K, Lott RS, Kerrick JM: Risperidone for aggression and self-injurious behavior in adults with mental retardation. J Autism Dev Disord 1998; 28:229-233
Lott RS, Kerrick JM, Cohen SA: Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. Psychopharmacol Bull 1996; 32:721-729
Dartnall NA, Holmes JP, Morgan SN, McDougle CJ: Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism. J Autism Dev Disord 1999; 29:87-91
Tassé MJ, Aman MG, Hammer D, Rojahn J: The Nisonger Child Behavior Rating Form: age and gender effect and norms. Res Dev Disabil 1996; 17:59-75
Aman MG, Tassé MJ, Rojahn J, Hammer D: The Nisonger CBRF: a child behavior rating form for children with developmental disabilities. Res Dev Disabil 1996; 17:41-57
Aman MG, Singh NN, Stewart AW, Field CJ: The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985; 89:485-491
Rojahn J, Matson JL, Lot D, Esbensen AJ, Smalls Y: The Behavior Problems Inventory: an instrument for the assessment of self-injury, stereotyped behavior, and aggression/destruction in individuals with developmental disabilities. J Autism Dev Disord 2001; 31:577-588
Chouinard G, Ross-Chouinard A, Annable L, Jones B: Extrapyramidal Symptom Rating Scale (abstract). Can J Neurol Sci 1980; 7:233
Platt JE, Campbell M, Grega DM, Green WH: Cognitive effects of haloperidol and lithium in aggressive conduct-disorder children. Psychopharmacol Bull 1984; 20:93-97